Healthcare >> Analyst Interviews >> May 8, 2002
KEVIN E. NOONAN has extensive experience in biotechnology and the
chemical arts. A registered patent agent since 1991, Dr. Noonan
brings over 10 years' experience as a molecular biologist working
on high-technology problems to his legal work. Dr. Noonan has
wide experience in all aspects of patent prosecution and client
counseling on validity, infringement, and patenting strategy
matters. He represents pharmaceutical and biotechnology companies
both large and small, and is particularly experienced in
representing university clients in both patent prosecution and
licensing to outside investors. Dr. Noonan received a PhD in
Molecular Biology from Princeton University, where his thesis
work involved genetic analysis of oncogenesis in mammalian cells.
Dr. Noonan was also a Postdoctoral Fellow supported by the
National Cancer Institute at the University of Illinois at
Chicago, where he studied multidrug resistance in mammalian tumor
cells. During his fellowship, Dr. Noonan developed a variety of
novel methods based on the polymerase chain reaction, including
quantitative analysis of mammalian gene expression. Dr. Noonan is
the author of several articles and has lectured extensively on
his scientific work. He graduated, cum laude, from the John
Marshall Law School and he is admitted to practice in Illinois
and Massachusetts. Dr. Noonan is currently an Adjunct Professor
of Law at the De Paul University Law School, where he teaches
biotechnology patent law. Profile
what you're doing?
Dr. Noonan: I do the whole range of IP representation for
clients, from patent prosecution and client
